Showing results (141-150 of 202) with videos related to

Sort By:
Pageof 21
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|June 24, 2020
Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-AKazumasa Fujitani, Kenichi Nakamura, Jyunki Mizusawa, et al.
The Journal of Cell Biology|July 7, 2010
Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora APoonam R Molli, Da-Qiang Li, Rozita Bagheri-Yarmand, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|February 10, 2020
Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)Takako Eguchi Nakajima, Kensei Yamaguchi, Narikazu Boku, et al.
The Lancet. Gastroenterology & Hepatology|November 24, 2019
Survival outcomes after laparoscopy-assisted distal gastrectomy versus open distal gastrectomy with nodal dissection for clinical stage IA or IB gastric cancer (JCOG0912): a multicentre, non-inferiority, phase 3 randomised controlled trialHitoshi Katai, Junki Mizusawa, Hiroshi Katayama, et al.
The Lancet. Gastroenterology & Hepatology|May 1, 2018
Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trialYukinori Kurokawa, Yuichiro Doki, Junki Mizusawa, et al.
Cell Motility and the Cytoskeleton|October 23, 2004
Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cellsKaori Sasai, Hiroshi Katayama, David L Stenoien, et al.
Japanese Journal of Clinical Oncology|August 27, 2014
A randomized controlled trial comparing laparoscopic surgery with open surgery in palliative resection of primary tumor in incurable Stage IV colorectal cancer: Japan Clinical Oncology Group Study JCOG 1107 (ENCORE trial)Masafumi Inomata, Tomonori Akagi, Hiroshi Katayama, et al.
Therapeutics and Clinical Risk Management|November 15, 2018
Descending necrotizing mediastinitis in a healthy young adultNobuaki Ochi, Tokio Wakabayashi, Atsushi Urakami, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|June 25, 2025
A Randomized Open-Label, Noninferiority, Phase 3, Multicenter, Controlled Trial to Compare Laparoscopic Surgery With Open Surgery for Symptomatic, Noncurable Stage IV Colorectal Cancer (JCOG1107)Tomonori Akagi, Masafumi Inomata, Ryo Kanzaka, et al.
Diseases of the Colon and Rectum|July 16, 2026
Three-Year Follow-Up of the Randomized Trial Comparing Open Versus Laparoscopic Surgery for Primary Tumor Resection in Patients With Non-Curable Stage IV Colon Cancer (JCOG1107)Akio Shiomi, Tomonori Akagi, Riku Kajikawa, et al.
Pageof 21